摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(4-氟-2-硝基苯基)吗啉 | 238418-75-2

中文名称
4-(4-氟-2-硝基苯基)吗啉
中文别名
——
英文名称
4-(4-fluoro-2-nitro-phenyl)morpholine
英文别名
4-(4-fluoro-2-nitrophenyl)morpholine
4-(4-氟-2-硝基苯基)吗啉化学式
CAS
238418-75-2
化学式
C10H11FN2O3
mdl
MFCD00798369
分子量
226.207
InChiKey
XEVFYVWDTJTEHQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    374.3±42.0 °C(Predicted)
  • 密度:
    1.340±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    16
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    58.3
  • 氢给体数:
    0
  • 氢受体数:
    5

安全信息

  • 海关编码:
    2934999090

SDS

SDS:a2443f67650f50824fb663918234bcaa
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 4-(4-Fluoro-2-nitrophenyl)morpholine
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 4-(4-Fluoro-2-nitrophenyl)morpholine
CAS number: 238418-75-2

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H11FN2O3
Molecular weight: 226.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-(4-氟-2-硝基苯基)吗啉 在 palladium 10% on activated carbon 、 甲酸铵 作用下, 以 甲醇 为溶剂, 反应 18.0h, 以81%的产率得到5-fluoro-2-morpholinoaniline
    参考文献:
    名称:
    Carbazole and Carboline Compounds for Use in the Diagnosis, Treatment, Alleviation or Prevention of Disorders Associated with Amyloid or Amyloid-Like Proteins
    摘要:
    本发明涉及可用于诊断、治疗、缓解或预防与淀粉样蛋白和类淀粉样蛋白相关的一组疾病和异常的新化合物,如阿尔茨海默病。本发明还提供了制备这些化合物的前体。
    公开号:
    US20170002005A1
  • 作为产物:
    描述:
    参考文献:
    名称:
    [EN] DIKETOPIPERAZINE DERIVATIVES AS P2X7 MODULATORS
    [FR] DÉRIVÉS DE DICÉTOPIPÉRAZINE COMME MODULATEURS DE P2X7
    摘要:
    本发明提供了一种式(I)化合物或其药学上可接受的盐:(I)其中:A代表芳基、杂芳基或杂环基团;上述芳基或杂芳基的任何环或环系可选地被1至3个取代基取代,这些取代基可以相同或不同,选自卤素、C1-6烷基、-CF3、-OCF3、氰基、C1-6烷氧基、-NR10R11、-X-芳基、-X-杂芳基和-X-杂环基;R1、R2、R3、R4和R5各自独立地代表氢、氟、氯、-CF3、氰基或C1-6烷基,使得R1、R2、R3、R4和R5中至少有一个不是氢;R6、R7、R8、R9、R10和R11各自独立地代表氢或C1-6烷基;X代表连接子,选自键、-(CH2)n-和-O-(CH2)n-;n代表1至3的整数。这些化合物或盐能够调节P2X7受体功能,并能拮抗ATP在P2X7受体上的效应(“P2X7受体拮抗剂”)。
    公开号:
    WO2010125103A1
点击查看最新优质反应信息

文献信息

  • [EN] CARBAZOLE AND CARBOLINE COMPOUNDS FOR USE IN THE DIAGNOSIS, TREATMENT, ALLEVIATION OR PREVENTION OF DISORDERS ASSOCIATED WITH AMYLOID OR AMYOLID-LIKE PROTEINS<br/>[FR] COMPOSÉS DE CARBAZOLE ET DE CARBOLINE DESTINÉS À ÊTRE UTILISÉS DANS LE DIAGNOSTIC, LE TRAITEMENT, L'ATTÉNUATION OU LA PRÉVENTION DE TROUBLES ASSOCIÉS AUX PROTÉINES AMYLOÏDES ET DE TYPE AMYLOÏDE
    申请人:AC IMMUNE SA
    公开号:WO2015110263A1
    公开(公告)日:2015-07-30
    The present invention relates to novel compounds that can be employed in the diagnosis, treatment, alleviation or prevention of a group of disorders and abnormalities associated with amyloid proteins and amyloid-like proteins, such as Alzheimer's disease. Precursors for the preparation of the compounds according to the present invention are also provided.
    本发明涉及一种新型化合物,可用于诊断、治疗、缓解或预防与淀粉样蛋白和类淀粉样蛋白相关的一组疾病和异常,如阿尔茨海默病。本发明还提供了制备这些化合物的前体。
  • [EN] ANTIBACTERIAL AGENTS: N(ALPHA)-AROYL-N-ARYL-PHENYLALANINAMIDES<br/>[FR] AGENTS ANTIBACTÉRIENS : N (ALPHA)-AROYL-N-ARYL-PHÉNYLALANINAMIDES
    申请人:UNIV RUTGERS
    公开号:WO2015120320A1
    公开(公告)日:2015-08-13
    The invention provides compounds having activity as bacterial RNA polymerase inhibitors and antibacterial agents, as well as compositions comprising the compounds and methods for their use. Specifically, phenylalanineamide and tyrosinamide compounds are disclosed that have inhibitory activity toward mycobacterium tuberculosis RNA polymerase. Use of these compounds in the treatment o prevention of M. tuberculosis infections in a mammal, is disclosed.
    该发明提供了具有细菌RNA聚合酶抑制剂和抗菌剂活性的化合物,以及包含这些化合物的组合物和它们的使用方法。具体地,揭示了对结核分枝杆菌RNA聚合酶具有抑制活性的苯丙氨酰胺和酪氨酰胺化合物。还揭示了在哺乳动物中使用这些化合物治疗或预防结核分枝杆菌感染的方法。
  • Decarboxylative <i>ipso</i> Amination of Activated Benzoic Acids
    作者:Martin Pichette Drapeau、Janet Bahri、Dominik Lichte、Lukas J. Gooßen
    DOI:10.1002/anie.201812068
    日期:2019.1.14
    the ligand and either air or N‐methylmorpholine N‐oxide as the oxidant, electron‐deficient benzoic acids undergo oxidative decarboxylative coupling with unprotected amines. This operationally simple aniline synthesis is widely applicable with respect to the amine and gives good yields, even on multigram scale. The orthogonality of this reaction to other Pd‐catalyzed crosscouplings allows the concise
    在以1,10-菲咯啉为配体,空气或N-甲基吗啉N-氧化物为氧化剂的双金属Pd / Cu体系存在下,缺电子的苯甲酸与未保护的胺进行氧化脱羧偶联。这种操作简单的苯胺合成方法在胺类方面具有广泛的应用,即使在数克规模上也能提供良好的收率。该反应与其他Pd催化的交叉偶联的正交性允许通过连续的C-C,C-Cl和C-N官能化简洁地合成多取代的芳烃。机理研究表明,是高价钯物种的中间产物。
  • ANTIBACTERIAL AGENTS: N(ALPHA)-AROYL-N-ARYL-PHENYLALANINAMIDES
    申请人:Rutgers, The State University of New Jersey
    公开号:EP3102193A1
    公开(公告)日:2016-12-14
  • US9919998B2
    申请人:——
    公开号:US9919998B2
    公开(公告)日:2018-03-20
查看更多

同类化合物

(4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (2-肟基-氰基乙酸乙酯)-N,N-二甲基-吗啉基脲六氟磷酸酯 鲸蜡基乙基吗啉氮鎓乙基硫酸盐 马啉乙磺酸钾 预分散OTOS-80 顺式4-(氮杂环丁烷-3-基)-2,2-二甲基吗啉 顺式-N-亚硝基-2,6-二甲基吗啉 顺式-3,5-二甲基吗啉 顺-2,6-二甲基-4-(4-硝基苯基)吗啉 非屈酯 雷奈佐利二聚体 阿瑞杂质9 阿瑞吡坦磷的二卞酯 阿瑞吡坦杂质 阿瑞吡坦杂质 阿瑞吡坦 阿瑞吡坦 阿瑞匹坦非对映异构体2R3R1R 阿瑞匹坦杂质A异构体 阿瑞匹坦杂质54 阿瑞匹坦-M3代谢物 钾[2 - (吗啉- 4 -基)乙氧基]甲基三氟硼酸 邻苯二甲酸单吗啉 调节安 试剂2-(4-Morpholino)ethyl2-bromoisobutyrate 茂硫磷 苯甲腈,2-(4-吗啉基)-5-[1,4,5,6-四氢-4-(羟甲基)-6-羰基-3-哒嗪基]- 苯甲曲秦 苯甲吗啉酮 苯基2-(2-苯基吗啉-4-基)乙基碳酸酯盐酸盐 苯二甲吗啉一氢酒石酸盐 苯二甲吗啉 苯乙酮 O-(吗啉基羰基甲基)肟 芬美曲秦 芬布酯盐酸盐 芬布酯 脾脏酪氨酸激酶(SYK)抑制剂 脱氯利伐沙班 脱氟雷奈佐利 羟基1-(3-氯苯基)-2-[(1,1-二甲基乙基)氨基]-1-丙酮盐酸盐 福沙匹坦苄酯 福沙匹坦杂质26 福曲他明 碘化N-甲基丙基吗啉 碘化N-甲基,乙基吗啉 硝酸吗啉 盐酸吗啡啉-D8 甲基吗啉-2-羧酸甲酯2,2,2-三氟乙酸盐 甲基N-[3-(乙酰基氨基)-4-[(2-氰基-4,6-二硝基苯基)偶氮]苯基]-N-乙基-&#x3B2-丙氨酸酸酯 甲基4-吗啉二硫代甲酸酯